BAE Systems (BA.) — Investment Research Note

Executive summary

BAE Systems is a top-tier global defence prime with balanced exposure across combat aircraft (Typhoon, F-35, GCAP/Tempest), naval (Type 26 frigates, Astute/Dreadnought submarines), combat vehicles (AMPV, CV90), electronic warfare/precision guidance, and space systems (via the 2024 Ball Aerospace acquisition). The 5-year trajectory has been extraordinary: sales £19.5bn (2021) → £30.7bn (2025), underlying EBIT margin steady at ~10.6–10.7%, EPS up from 47.8p to 75.2p, and order backlog rising from £44bn to £75.4bn — the story is a fundamental rerating driven by post-Ukraine European defence spending, AUKUS, GCAP, and successful US M&A. The single most important valuation point today is that this quality is fully recognised: at 1,936p the shares sit near a 23x forward P/E, above the historical defence range, so the outlook is priced in.

Fair value estimate

• Methodology: forward-earnings multiple, cross-checked against peer defence primes.
• 2026 guidance midpoint: EPS growth +9–11% on 75.2p → ~83p 2026E; running to ~91p 2027E at ~10%.
• Peer multiple range: large defence primes (LMT, NOC, RTX, Rheinmetall, Rolls-Royce) currently trade ~18–23x forward earnings, with premium given for order backlog visibility.
• Applying 20–23x to 2026E EPS of 83p → 1,660p – 1,910p per share.
• Extending to a 2027E view (91p × 20–22x) gives 1,820p – 2,000p.
• Fair value range: 1,700p – 1,950p, midpoint ~1,825p → implied market cap ~£53.5bn (vs current £55.1bn).
• Absolute upside/downside vs current 1,936p: roughly −12% to +1% (mid-point ~−6%). The stock is priced at or slightly above fair value; the bull case is largely embedded.

Sector context

• ICB classification is confirmed as Industrials / Industrial Goods & Services, though BAE is functionally a defence prime — a distinct sub-sector.
• Profile is above sector-average quality (long-cycle order backlog >2 years of revenue, government-underwritten cash flows) and higher growth than typical UK industrials currently, but leverage (~1.7x net debt / EBITDA including post-Ball Aerospace debt) is somewhat elevated relative to net-cash defence peers.
• Listed peers: Lockheed Martin (US, direct comp), RTX, Northrop Grumman, Rheinmetall (European land systems), Rolls-Royce (UK defence/civil aerospace).

Investment thesis

• Structural European/NATO rearmament with confirmed customer commitment. NATO 5% GDP target agreed at June 2025 summit (3.5% core + 1.5% defence-adjacent); UK 2.5% by 2027 and 4.1% by 2035 targets; German Quadriga and Türkiye Typhoon (£2.5bn 2026) 2025-11 trading update; 2025-07 H1. Order backlog £75.4bn provides ~2.5 years of revenue coverage.
• AUKUS/GCAP + Ball Aerospace materially extend the growth runway. SSN-AUKUS UK design authority secured (£3.95bn Delivery Phase 3 funding, subsequent Norway Type 26 win); Ball Aerospace ($5.5bn, closed Feb 2024) added ~$2bn revenue in high-growth space/C4ISR with 10% CAGR guidance and margin-accretive backlog 2024-02 final results; 2025-11 trading update.
• Balance-sheet-supported capital returns. Rolling dividend increase (33.0p 2024 → guided FY26), plus £1.5bn buyback ~62% complete by May 2026 (£930m repurchased). Free cash flow >£1.3bn in 2026 with cumulative £5.5bn+ 2025-2027 target 2026-05 trading update; 2025-02 final results.

Key risks

• Valuation is stretched relative to defence-industry historical norms. At ~23x forward EPS the stock has re-rated ~50% in three years; multiple compression toward historical 15–18x on any peace-dividend narrative or budget disappointment could produce material downside [inferred from market data and peer comparison].
• US budget/political risk. ~46% of revenue is US-derived; the November 2025 trading update flagged a US government shutdown risk and delayed contract funding as possible; sensitivity to defence appropriations bill timing and future administration priorities is real 2025-11 trading update.
• Saudi/Salam Typhoon export licence and contract renewal risk. ~£2.5bn of 2025 revenue from Saudi Arabia; long-running dependence on Salam programme and successive five-year support contracts (renewed to 2027); geopolitics and export-licence policy remain a latent overhang 2025-02 final results; 2024-08 H1.

Operating leverage

Defence primes have modest, not high, operating leverage. BAE's return on sales has been remarkably stable at 10.4–10.7% over five years despite 57% revenue growth — evidence that incremental revenue converts largely at target contract margin rather than dropping disproportionately to profit. Most contracts are cost-plus or fixed-price with regulated profit ceilings on UK submarines (visible in Maritime's 6.8–8.4% margin), which mechanically caps upside on revenue surprises. Meaningful capacity investment is under way (Glasgow shipbuild hall, Sheffield artillery factory, Barrow submarine expansion, Hägglunds capacity) — this is capex to enable contracted growth, not spare capacity. Electronic Systems (~15% margin, benefiting from Ball Aerospace synergies) shows the most operating leverage, but for the Group a 10% revenue beat would likely translate into ~11–13% EBIT growth, not a multi-x profit surprise. This is not a high-operating-leverage business by the investor's definition. 2025-07 half-year; 2025-02 final results segmental review.

Value-trap signals

None identified. Revenue and EPS growing; dividend rising for 20+ consecutive years; backlog at record; buyback active; auditor's report unqualified; going-concern intact; no restatements; no customer concentration risk >~15% single-country outside US/UK. The risk here is overvaluation, not value-trap dynamics.

Earnings vs. expectations

Across the 5-year period, BAE has a consistent pattern of meeting or upgrading guidance. 2023 full-year: original guidance sales +3–5% / EBIT +4–6% was upgraded twice in-year (H1 upgrade to +5–7% / +6–8%, delivered ~9% / ~14% on constant currency). 2024 full-year: original sales +10–12% guidance upgraded at H1 to +12–14%, delivered 14%. 2025: guidance upgraded at H1 (sales +8–10%, EBIT +9–11%), maintained through year-end. 2026: guidance reaffirmed at May AGM. Pattern: management guides conservatively then upgrades; the business consistently over-delivers on operational metrics, though FCF has occasionally surprised negatively (H1 2025 £(368)m outflow vs +£219m PY on customer-advance timing) before recovering. Analyst consensus is not disclosed within the filings but management guidance has proven a reliable floor.

Conviction

Conviction: 4 (high). Anchors: (i) exceptionally clear disclosure with ten years of consistent alternative performance measures and reconciliations; (ii) record order backlog of £75.4bn gives 2.5-year revenue visibility, making the EPS forward path near-mechanical; (iii) peer multiples for defence primes are well-established and the 20–23x range is well-supported. Limiting factors: (i) rerating potential either way depends on macro/geopolitical narrative that is inherently unpredictable; (ii) the Ball Aerospace synergy realisation remains partly unproven, though early execution is on track.

Driver scoring rationale (summary)

BAE is a classic quality-defence-industrial — strong balance sheet resilience, government-underwritten cash flows, and secular tailwind — but it is not the type of AI beneficiary this investor is targeting, has modest operating leverage, and is priced fully. Space and cyber businesses provide some indirect AI exposure but they are not the value drivers. This is a partial-fit name that would score in the mid-band.